Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
07 February 2018Website:
http://www.renovarobio.comNext earnings report:
14 November 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | 17 min agoDividend
Analysts recommendations
Institutional Ownership
RENB Latest News
LOS ANGELES, June 14, 2024 (GLOBE NEWSWIRE) -- Renovaro, Inc. (NASDAQ: RENB) (the “Company”) announces that it has $10 million in additional equity committed at a price per share of $1.4726 and 10 percent warrant coverage. “We appreciate confidence in the Company demonstrated by the investors,” said the Hon.
What type of business is Renovaro Biosciences?
Renovaro Biosciences Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer in the United States. The company's product pipeline includes RENB-HV-01 for autologous HIV curative treatment; RENB-HV-12, a therapeutic HIV vaccine; and RENB-HB-01, a gene therapy curative treatment for HBV. It also develops RENB-DC-11, an allogeneic dendritic cell therapeutic vaccine for pancreatic cancer; RENB-DC-12-XX, an allogeneic dendritic cell therapeutic vaccine for other solid tumors; and RENB-HV-21 for treating HIV with allogeneic natural killer (NK) and gamma delta T-cells. It has strategic partnerships with the University of California, Fred Hutchinson Cancer Research Center, and Caring Cross. The company was formerly known as Enochian Biosciences, Inc. and changed its name to Renovaro Biosciences Inc. in August 2023. Renovaro Biosciences Inc. is headquartered in Los Angeles, California.
What sector is Renovaro Biosciences in?
Renovaro Biosciences is in the Healthcare sector
What industry is Renovaro Biosciences in?
Renovaro Biosciences is in the Biotechnology industry
What country is Renovaro Biosciences from?
Renovaro Biosciences is headquartered in United States
When did Renovaro Biosciences go public?
Renovaro Biosciences initial public offering (IPO) was on 07 February 2018
What is Renovaro Biosciences website?
https://www.renovarobio.com
Is Renovaro Biosciences in the S&P 500?
No, Renovaro Biosciences is not included in the S&P 500 index
Is Renovaro Biosciences in the NASDAQ 100?
No, Renovaro Biosciences is not included in the NASDAQ 100 index
Is Renovaro Biosciences in the Dow Jones?
No, Renovaro Biosciences is not included in the Dow Jones index
When does Renovaro Biosciences report earnings?
The next expected earnings date for Renovaro Biosciences is 14 November 2024